Dr Lalezari is direct. A statement he made in an interview about Leronlimab treating CV-19:

“We are still waiting for the results of randomized, placebo-controlled studies. In the meantime, the FDA has been distracted by the foolishness around hydroxychloroquine and Remdesivir.

I believe the former is more harmful than helpful, and the latter is at best marginally helpful and only if started very early. I believe the time and energy those two drugs have taken up has prevented the FDA from seeing or understanding what’s happening with Leronlimab. “


Sounds kind of like Joe discussing some of the current vaccine platforms vs NGIO's "complete vaccine".